Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering
SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (âCalidiâ or the âCompanyâ), a biotechnology company pioneering the development of targeted genetic medicines, today announced that...